BC
OPTN

Broadfin Capital’s OptiNose OPTN Stock Holding History

Broadfin Capital’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,727
Closed -$4.22M – 49
2019
Q2 		$4.22M Buy
39,727
+687
+2% +$90.5K 0.92% 31
2019
Q1 		$6.03M Sell
39,040
-8,333
-18% -$966K 1.25% 29
2018
Q4 		$4.41M Buy
+47,373
New +$6.77M 0.58% 37

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital's OPTN Position: Q3 2019 in Review

Broadfin Capital sold out of OptiNose (OPTN) in Q3 2019, closing a stake of 39,727 shares — an estimated $4.22M sold.

Broadfin Capital first reported a position in OPTN in Q4 2018 and held it in 3 quarters. The position peaked at $6.03M in Q1 2019. 77 funds tracked by Wall St. Rank hold OPTN as of Q3 2019.

  • Broadfin Capital reported no remaining OptiNose position as of Q3 2019 after selling out during the quarter.
  • Broadfin Capital sold 39,727 OptiNose shares in Q3 2019, an estimated $4.22M.
  • Broadfin Capital first reported a position in OptiNose in Q4 2018 and held it in 3 quarters.
  • Broadfin Capital's OptiNose position peaked at $6.03M in Q1 2019.
  • 77 funds tracked by Wall St. Rank held OptiNose as of Q3 2019.

Based on Broadfin Capital's 13F filing for Q3 2019, filed 14 Nov 2019.